You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 9, September 1987 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (38)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sclerosing Agents in the Treatment of Telangiectasia

Comparison of the Clinical and Histologic Effects of Intravascular Polidocanol, Sodium Tetradecyl Sulfate, and Hypertonic Saline in the Dorsal Rabbit Ear Vein Model

Mitchel P. Goldman, MD; Richard P. Kaplan, MD; Lisa N. Oki; Patricia A. Cavender, MD; Richard A. Strick, MD; Richard G. Bennett, MD

Arch Dermatol. 1987;123(9):1196-1201.


Abstract

• A 0.25-mL quantity of 0.25%, 0.5%, and 1.0% polidocanol (Aethoxysclerol [France]), 0.5% sodium tetradecyl sulfate (Sotradecol Injection), and 23.4% hypertonic saline was injected into the dorsal marginal rabbit ear vein; clinical and histologic thrombosis resulted that lasted between four and eight days. The lowest concentration of polidocanol (0.25%) demonstrated immediate thrombosis; however, no clinical or histologic changes occurred eight days after injection. With all other agents, histologic fibrosis of the vessel correlating with clinical disappearance occurred after eight days. However, 0.5% polidocanol and sodium tetradecyl sulfate developed recanalization through the initially sclerosed vessel between eight and 14 days, with clinical reappearance of the 0.5% polidocanol-injected vessel at 30 days, after injection. Cutaneous necrosis was noted clinically and histologically in three of ten vessels injected with 1.0% polidocanol and in two of ten vessels injected with hypertonic saline. Clinical and histologic evidence of necrosis occurred with and without extravasation of the sclerosants.

(Arch Dermatol 1987;123:1196-1201)



Author Affiliations

From the Division of Dermatology, Department of Medicine, UCLA.


Footnotes

Accepted for publication March 24, 1987.

Read in part before the annual meeting of the American Society for Dermatologic Surgery, Palm Springs, Calif, April 4,1986, and the 45th annual meeting of the American Academy of Dermatology, New Orleans, Dec 6, 1986.

Reprint requests to 850 Prospect St, Suite 2, La Jolla, CA 92037 (Dr Goldman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Treatment of Angiomas with Sclerosing Injection of Hydroxypolyethoxydodecan
Seccia and Salgarello
ANGIOLOGY 1991;42:23-29.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1987 American Medical Association. All Rights Reserved.